Table 2.

Percentage of Cells with Nucleolar SSRP1 after Cisplatin Treatment

Cell lineCisplatin (h)P
012.54
MDA-MB-23162.7 (47-74)67.3 (53-89)5.3 (3-9)3.7 (0-11)<0.001
MDA-MB-46843.3 (32-41)44.0 (34-58)2.3 (0-7)3.0 (0-6)<0.001
SkBr366.7 (41-92)58.7 (42-76)4.7 (0-14)0.3 (0-1)<0.001
BT47457.3 (49-63)60.0 (45-71)9.7 (4-15)9.0 (2-13)<0.001